HPV screening for cervical cancer in rural India. Mwanahamuntu MH, Sahasrabuddhe VV, Parham GP (2009) N Engl J Med 361: 305; author reply 306 Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Pattillo RA, Hussa RO, Story MT, Ruckert AC, Shalaby MR, Mattingly RF (1977) Science 196: 1456-8 Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality. Sahasrabuddhe VV, Sherman ME (2012) J Natl Cancer Inst 104: 1698-701 The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents. Kreimer AR, Sherman ME, Sahasrabuddhe VV, Safaeian M (2015) J Natl Cancer Inst 107: Decreased plasma beta-carotene levels in women with uterine cervical dysplasias and cancer. Palan PR, Romney SL, Mikhail M, Basu J, Vermund SH (1988) J Natl Cancer Inst 80: 454-5 Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L, Cho KR (1993) Proc Natl Acad Sci U S A 90: 3988-92 Vaginal douching: evidence for risks or benefits to women's health. Martino JL, Vermund SH (2002) Epidemiol Rev 24: 109-24 FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Hendricks DT, Taylor R, Reed M, Birrer MJ (1997) Cancer Res 57: 2112-5 Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP (2009) AIDS 23: N1-5 On 'the natural history of HIV and AIDS in women'. Kelley KF, Vermund SH (1992) AIDS 6: 1406-8 Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Morrison EA, Ho GY, Vermund SH, Goldberg GL, Kadish AS, Kelley KF, Burk RD (1991) Int J Cancer 49: 6-13 Genital papillomavirus infection and cervical dysplasia--opportunistic complications of HIV infection. Laga M, Icenogle JP, Marsella R, Manoka AT, Nzila N, Ryder RW, Vermund SH, Heyward WL, Nelson A, Reeves WC (1992) Int J Cancer 50: 45-8 Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India. Sahasrabuddhe VV, Bhosale RA, Kavatkar AN, Nagwanshi CA, Joshi SN, Jenkins CA, Shepherd BE, Kelkar RS, Sahay S, Risbud AR, Vermund SH, Mehendale SM (2012) Int J Cancer 130: 234-40 EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, Monsonego J, Franceschi S (2015) Int J Cancer 136: 2752-60 Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. Wilson LE, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N (2013) Int J Cancer 133: 2172-81 Src induces morphological changes in A431 cells that resemble epidermal differentiation through an SH3- and Ras-independent pathway. Jin F, Reynolds AB, Hines MD, Jensen PJ, Johnson KR, Wheelock MJ (1999) J Cell Sci 112 ( Pt 17): 2913-24 Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. Klein RS, Ho GY, Vermund SH, Fleming I, Burk RD (1994) J Infect Dis 170: 1404-9 Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Hiebert SW (1993) Mol Cell Biol 13: 3384-91 Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Mwanahamuntu MH, Sahasrabuddhe VV, Stringer JS, Parham GP (2008) Bull World Health Organ 86: D-E Impact of the Bethesda System. Jones HW (1995) Cancer 76: 1914-8 Acute lymphoblastic leukemia. An unusual case of primary relapse in the uterine cervix. Zutter MM, Gersell DJ (1990) Cancer 66: 1002-4 Cervical cancer. Greer BE, Koh WJ, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Copeland L, Crispens MA, Dupont N, Eifel PJ, Gaffney DK, Huh WK, Kapp DS, Lurain JR, Martin L, Morgan MA, Morgan RJ, Mutch D, Remmenga SW, Reynolds RK, Small W, Teng N, Valea FA, National Comprehensive Cancer Networks (2010) J Natl Compr Canc Netw 8: 1388-416 Cervical cancer. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Cohn D, Crispens MA, DuPont N, Eifel PJ, Gaffney DK, Giuntoli RL, Han E, Huh WK, Lurain JR, Martin L, Morgan MA, Mutch D, Remmenga SW, Reynolds RK, Small W, Teng N, Tillmanns T, Valea FA, McMillian NR, Hughes M, National Comprehensive Cancer Network (2013) J Natl Compr Canc Netw 11: 320-43 Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM (1987) J Virol 61: 962-71 Incidence and mortality of gynaecological cancers: Secular trends in urban Shanghai, China over 40 years. Huang Z, Zheng Y, Wen W, Wu C, Bao P, Wang C, Zhong W, Gao YT, Jin F, Xiang YB, Shu XO, Beeghly-Fadiel A (2016) Eur J Cancer 63: 1-10 Squamous carcinoma of the cervix complicating pregnancy: recurrence in episiotomy after vaginal delivery. Gordon AN, Jensen R, Jones HW (1989) Obstet Gynecol 73: 850-2 Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates. Lang Kuhs KA, Porras C, Schiller JT, Rodriguez AC, Schiffman M, Gonzalez P, Wacholder S, Ghosh A, Li Y, Lowy DR, Kreimer AR, Poncelet S, Schussler J, Quint W, van Doorn LJ, Sherman ME, Sidawy M, Herrero R, Hildesheim A, Safaeian M, Costa Rica Vaccine Trial Group (2014) Am J Epidemiol 180: 599-607 Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. Abraham AG, D'Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, Saag MS, Rourke SB, Rachlis A, Napravnik S, Moore RD, Klein MB, Kitahata MM, Kirk GD, Hogg RS, Hessol NA, Goedert JJ, Gill MJ, Gebo KA, Eron JJ, Engels EA, Dubrow R, Crane HM, Brooks JT, Bosch RJ, Strickler HD, North American AIDS Cohort Collaboration on Research and Design of IeDEA (2013) J Acquir Immune Defic Syndr 62: 405-13 Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia. Kapambwe S, Sahasrabuddhe VV, Blevins M, Mwanahamuntu MH, Mudenda V, Shepherd BE, Chibwesha CJ, Pfaendler KS, Hicks ML, Vermund SH, Stringer JS, Parham GP (2015) J Acquir Immune Defic Syndr 70: e20-6 Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. Bateman AC, Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Kapambwe S, Katundu K, Nkole T, Mulundika J, Pfaendler KS, Hicks ML, Shibemba A, Vermund SH, Stringer JS, Chibwesha CJ (2014) J Acquir Immune Defic Syndr 67: 212-5 p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Kessis TD, Slebos RJ, Han SM, Shah K, Bosch XF, Muñoz N, Hedrick L, Cho KR (1993) Am J Pathol 143: 1398-405 Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM (1985) Am J Pathol 119: 361-6 Plasma reduced and total ascorbic acid in human uterine cervix dysplasias and cancer. Romney SL, Basu J, Vermund S, Palan PR, Duttagupta C (1987) Ann N Y Acad Sci 498: 132-43 Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM (2000) Arch Pediatr Adolesc Med 154: 127-34 Expanding Cervical Cancer Screening and Treatment in Tanzania: Stakeholders' Perceptions of Structural Influences on Scale-Up. McCree R, Giattas MR, Sahasrabuddhe VV, Jolly PE, Martin MY, Usdan SL, Kohler C, Lisovicz N (2015) Oncologist 20: 621-6 Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Sahasrabuddhe VV, Luhn P, Wentzensen N (2011) Future Microbiol 6: 1083-98 Implementation of cervical cancer screening using visual inspection with acetic acid in rural Mozambique: successes and challenges using HIV care and treatment programme investments in Zambézia Province. Moon TD, Silva-Matos C, Cordoso A, Baptista AJ, Sidat M, Vermund SH (2012) J Int AIDS Soc 15: 17406 Functional variants in CYP1A1 and GSTM1 are associated with clearance of cervical HPV infection. Sudenga SL, Shrestha S, Macaluso M, Partridge EE, Johanning GL, Piyathilake CJ (2014) Gynecol Oncol 135: 560-4 Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JS, Parham GP (2008) Gynecol Oncol 110: 402-7 Squamous cell carcinoma of the cervix presenting as lymphangitic carcinomatosis: a case report and review of the literature. Storck K, Crispens M, Brader K (2004) Gynecol Oncol 94: 825-8
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.